Formulation of solid dispersion of rebamipide evaluated in a rat model for improved bioavailability and efficacy

Journal of Pharmacy and Pharmacology

Volumn 63, Issue 12, 2011, Pages 1539-1547

  Tung, Nguyen Thach ^a   Park, Chun Woong ^a   Oh, Tack Oon ^a   Kim, Ju Young ^a   Ha, Jung Myung ^a   Rhee, Yun Seok ^b   Park, Eun Seok ^a  

^a Sungkyunkwan University   (South Korea)

^b Gyeongsang National University   (South Korea)

Author keywords

pharmacodynamic; pharmacokinetic; rebamipide; solid dispersion

Indexed keywords

REBAMIPIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DISPERSION; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG FORMULATION; DRUG SOLUBILITY; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; RAT; SPRAY DRYING; STOMACH PROTECTION; STOMACH ULCER; TIME TO MAXIMUM PLASMA CONCENTRATION;

ALANINE; ALGORITHMS; ANIMALS; ANTI-ULCER AGENTS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HALF-LIFE; MALE; QUINOLONES; RATS; RATS, SPRAGUE-DAWLEY; SOLUBILITY; SOLVENTS; SPECTROMETRY, FLUORESCENCE; SPECTROPHOTOMETRY, ULTRAVIOLET; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 80855132475     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2011.01360.x     Document Type: Article

References (18)

1. Arakawa T, et al,. 15th anniversary of rebamipide: looking ahead to the new mechanisms and new applications. Dig Dis Sci 2005; (Suppl. 1) 50: S3-S11. (Pubitemid 41380792)
2. Miyake M, et al,. Optimization of suppository preparation containing sodium laurate and taurine that can safely improve rectal absorption of rebamipide. Biol Pharm Bull 2006; 2: 330-335. (Pubitemid 43200906)
3. Mukaizawa F, et al,. Novel oral absorption system containing polyamines and bile salts enhances drug transport via both transcellular and paracellular pathways across Caco-2 cell monolayers. Int J Pharm 2009; 1-2: 103-108.
4. Beom SS, et al,. Oral absorption and pharmacokinetics of rebamipide and rebamipide lysinate in rats. Drug Dev Ind Pharm 2004; 8: 869-876. (Pubitemid 39362871)
5. Fernandes CM, et al,. Physicochemical characterization and in vitro dissolution behavior of nicardipine-cyclodextrins inclusion compounds. Eur J Pharm Sci 2002; 1: 79-88. (Pubitemid 34136971)
6. Rabinow BE,. Nanosuspensions in drug delivery. Nat Rev Drug Discov 2004; 9: 785-796. (Pubitemid 39242830)
7. Sanghvi R, et al,. Solubility improvement of drugs using N-methyl pyrrolidone. AAPS PharmSciTech 2008; 2: 366-376.
8. Ghosh I, et al,. Nanosuspension for improving the bioavailability of a poorly soluble drug and screening of stabilizing agents to inhibit crystal growth. Int J Pharm 2011; 1-2: 260-268.
9. Son DC, et al,. High performance liquid chromatographic analysis of rebamipide in human plasma. Anal Lett 2005; 6: 997-1005. (Pubitemid 40600501)
10. Dumortier G, et al,. A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res 2006; 12: 2709-2728. (Pubitemid 44885361)
11. Janssens S, et al,. Formulation and characterization of ternary solid dispersions made up of Itraconazole and two excipients, TPGS 1000 and PVPVA 64, that were selected based on a supersaturation screening study. Eur J Pharm Biopharm 2008; 1: 158-166.
12. Six K, et al,. Increased physical stability and improved dissolution properties of itraconazole, a class II drug, by solid dispersions that combine fast- and slow-dissolving polymers. J Pharm Sci 2004; 1: 124-131. (Pubitemid 38081820)
13. Wang X, et al,. Solid state characteristics of ternary solid dispersions composed of PVP VA64, Myrj 52 and itraconazole. Int J Pharm 2005; 1-2: 54-61. (Pubitemid 41318021)
14. Matsumoto T, Zografi G,. Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization. Pharm Res 1999; 11: 1722-1728. (Pubitemid 29530405)
15. Taylor LS, Zografi G,. Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm Res 1997; 12: 1691-1698. (Pubitemid 28062912)
16. Wong SM, et al,. Enhancement of the dissolution rate and oral absorption of a poorly water soluble drug by formation of surfactant-containing microparticles. Int J Pharm 2006; 1: 61-68. (Pubitemid 43866347)
17. Yamasaki K, et al,. Gastric mucosal protection by OPC-12759, a novel antiulcer compound, in the rat. Eur J Pharmacol 1987; 1: 23-29. (Pubitemid 17159903)
18. Yamasaki K, et al,. Effect of OPC-12759, a novel antiulcer agent, on chronic and acute experimental gastric ulcer, and gastric secretion in rats. Jpn J Pharmacol 1989; 4: 441-448. (Pubitemid 19107719)